In-use stability assessment of FDA approved metformin immediate release and extended release products for N-Nitrosodimethylamine and dissolution quality attributes-Reference-Cited by-同舟云学术

In-use stability assessment of FDA approved metformin immediate release and extended release products for N-Nitrosodimethylamine and dissolution quality attributes

Published:2022-07 Issue: Volume:623 Page:121923
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Dharani Sathish,Mohamed Eman M.,Khuroo Tahir,Ali Hamed I.,Reddy Indra K.,Rahman Ziyaur,Khan Mansoor A.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Ashp@drug shortages. Current drug shortage bulletins. May 2021. https://www.ashp.org/Drug- Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=730. Accessed on May 25, 2021.

2. Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate;Awotwe-Otoo;J. Pharm. Biomed. Anal.,2012

3. Quality and in-use stability comparison of brand and generics of extended release phenytoin sodium capsules;Dharani;J. Pharm. Sci.,2019

4. Development and validation of an LC–MS/MS method for the determination of adapalene in pharmaceutical forms for skin application;Dobricic;J. Serb. Chem. Soc.,2016

5. Drugs@FDA Glossary of Terms. https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-glossary-terms#TE. 2017. Accessed on June 27 2021.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices;Chemical Research in Toxicology;2024-08-19

2. Nitrosamine Impurities in Pharmaceuticals: An Empirical Review of their Detection, Mechanisms, and Regulatory Approaches;Current Topics in Medicinal Chemistry;2024-03

3. Patient In-Use Stability Testing of FDA-Approved Metformin Combination Products for N-Nitrosamine Impurity;AAPS PharmSciTech;2024-01-24

4. Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets;Journal of Pharmaceutical Sciences;2023-12

5. N-Nitrosodimethylamine Formation in Metformin Drug Products by the Reaction of Dimethylamine and Atmospheric NO₂;Organic Process Research & Development;2023-11-02